Author:
Monsuez J.-J.,Ikhefoulma S.,Mahiou A.,Landré T.
Subject
Cardiology and Cardiovascular Medicine
Reference19 articles.
1. Task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of diabetes (EASD). Ryden L, Standt E, Bartnik M, et coll. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136.
2. Action to Control Risk in Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering In type 2 diabetes. N Engl J Med 2008;358 2545-59.
3. ADVANCE collaborative Group. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
4. ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus. Lancet 2007;370:829-40.
5. Skyler JS, Bergenstal R, O Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE and VA diabetes trials. Circulation 2009;119: 351-7.